Deep vein thrombosis. Deep vein thrombosis NOS
Conditions
Interventions
Intervention 1: control goup:
Catheter guided thrombolysis.
Prior to thrombolysis all patients will be given heparin 1000 U/h. PTT will be evaluated and heparin dose will be adjusted based on patient
if there be an underlying stenotic lesion, balloon angioplasty and stenting will be performed as a supplementary procedure. Intervention 2: Intervention group: mechanical thrombectomy with Aspirex Dev
Treatment - Drugs
Treatment - Devices
control goup:
Catheter guided thrombolysis.
Prior to thrombolysis all patients will be given heparin 1000 U/h. PTT will be evaluated and heparin dose will be adjusted based on patient’s PTT.
While
if there be an underlying stenotic lesion, balloon angioplasty and stenting will be performed as a supplementary procedure.
Intervention group: mechanical thrombectomy with Aspirex Device.Prior to thrombolysis all patients will be given heparin 1000 U/h. PTT will be evaluated and heparin dose will be adjusted based on pati
Sponsors
Vice Chancellor for research of Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: all the patients aged less than 60 years old with the onset of symptoms less than 2 weeks that initial diagnosis of acute ileofemoral deep vein thrombosis has been made by Doppler ultrasound and definite diagnosis has been made by venography and are a candidate for treatment Exclusion criteria: patients with heart, renal or pulmonary failure; and the patients with the diagnosis of DVT after two weeks of symptoms onset
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of the treatment. Timepoint: During hospitalization. Method of measurement: The time recorded in the checklist.;The success rate of the treatment. Timepoint: During hospitalization after treatment. Method of measurement: venography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospitalization. Timepoint: During hospitalization. Method of measurement: The time recorded in the checklist.;Complications during the treatment. Timepoint: During treatment. Method of measurement: Physical examination and Lab tests.;Complete Thrombus lysis. Timepoint: During hospitalization after treatment. Method of measurement: Venography.;Improvement of the primary symptoms. Timepoint: During hospitalization, 2 weeks, 1 month, 45 days and 6 manoths after intervention. Method of measurement: Physical examination.;Complications during hospitalization. Timepoint: During hospitalization. Method of measurement: Physical examination and Lab tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Maziar Moayeri Far
Vascular surgery and Dialysis research center
Outcome results
None listed